Nicotinic acid inhibits hepaticAPOAgene expression: studies in humans and in transgenic mice

FGF19 Signaling Cascade Suppresses APOA Gene Expression

(2012) Indumathi Chennamsetty et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments

(2011) Janet E. Digby et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1

(2011) Ben J. Wu et al.   CIRCULATION

Optimal pharmacotherapy to combat the atherogenic lipid triad

(2011) M. John Chapman et al.   CURRENT OPINION IN CARDIOLOGY

Pleiotropic Effects of Nicotinic Acid: Beyond High Density Lipoprotein Cholesterol Elevation

(2011) Matilda Florentin et al.   Current Vascular Pharmacology

Farnesoid X receptor represses hepatic human APOA gene expression

(2011) Indumathi Chennamsetty et al.   JOURNAL OF CLINICAL INVESTIGATION

Optimal therapy for reduction of lipoprotein(a)

(2011) G. Lippi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes

(2010) Xiaoyu Li et al.   BIOCHEMICAL PHARMACOLOGY

Lp(a) Lipoprotein/pre-β1-lipoprotein, serum lipids and atherosclerotic disease

(2010) G. DAHLEN et al.   CLINICAL GENETICS

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Apolipoprotein(a) Isoforms and the Risk of Vascular Disease

(2010) Sebhat Erqou et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk

(2010) M. John Chapman et al.   PHARMACOLOGY & THERAPEUTICS

Nicotinic acid and the prevention of coronary artery disease

(2009) Janet E Digby et al.   CURRENT OPINION IN LIPIDOLOGY

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

(2009) Pia R. Kamstrup   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease

(2009) David-Alexandre Trégouët et al.   NATURE GENETICS

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

(2009) Robert Clarke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin and Lipoprotein(a): Facts, Uncertainties, and Clinical Considerations

(2008) Angelo M. Scanu et al.   AMERICAN JOURNAL OF CARDIOLOGY

Mechanism of Action of Niacin

(2008) Vaijinath S. Kamanna et al.   AMERICAN JOURNAL OF CARDIOLOGY

The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity

(2008) Sotirios Tsimikas et al.   CURRENT OPINION IN LIPIDOLOGY